Galapagos Diversifies into Antibodies

By Sally Mardikian PhD

Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)

Published: 26 Nov-2008

DOI: 10.3833/pdr.v2008.i102.104     ISSN: 1756-7874

Section: Licensing



Galapagos has entered into an agreement with MorphoSys to develop therapeutic antibodies from discovery through to Phase IIa clinical trials within the bone and joint disease area...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details